Clarius Group LLC’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $542K | Buy |
1,983
+9
| +0.5% | +$2.45K | 0.03% | 193 |
|
|
2025
Q3 | $533K | Sell |
1,974
-364
| -16% | -$99K | 0.03% | 198 |
|
|
2025
Q2 | $644K | Buy |
2,338
+682
| +41% | +$185K | 0.04% | 207 |
|
|
2025
Q1 | $439K | Buy |
1,656
+30
| +2% | +$7.4K | 0.03% | 265 |
|
|
2024
Q4 | $378K | Sell |
1,626
-7
| -0.4% | -$1.61K | 0.03% | 266 |
|
|
2024
Q3 | $356K | Sell |
1,633
-53
| -3% | -$11K | 0.03% | 280 |
|
|
2024
Q2 | $331K | Sell |
1,686
-22
| -1% | -$4.54K | 0.02% | 295 |
|
|
2024
Q1 | $368K | Sell |
1,708
-426
| -20% | -$89.5K | 0.03% | 288 |
|
|
2023
Q4 | $449K | Sell |
2,134
-147
| -6% | -$31.4K | 0.04% | 252 |
|
|
2023
Q3 | $457K | Sell |
2,281
-186
| -8% | -$37K | 0.04% | 236 |
|
|
2023
Q2 | $457K | Sell |
2,467
-265
| -10% | -$49K | 0.04% | 278 |
|
|
2023
Q1 | $523K | Sell |
2,732
-6,987
| -72% | -$1.26M | 0.04% | 246 |
|
|
2022
Q4 | $1.63M | Buy |
9,719
+7,104
| +272% | +$1.23M | 0.15% | 86 |
|
|
2022
Q3 | $463K | Buy |
2,615
+199
| +8% | +$39.3K | 0.05% | 228 |
|
|
2022
Q2 | $495K | Buy |
2,416
+236
| +11% | +$50K | 0.05% | 216 |
|
|
2022
Q1 | $498K | Hold |
2,180
| – | – | 0.04% | 242 |
|
|
2021
Q4 | $498K | Buy |
2,180
+156
| +8% | +$34.3K | 0.04% | 242 |
|
|
2021
Q3 | $391K | Sell |
2,024
-20
| -1% | -$4.05K | 0.04% | 265 |
|
|
2021
Q2 | $435K | Sell |
2,044
-261
| -11% | -$55.1K | 0.04% | 240 |
|
|
2021
Q1 | $471K | Buy |
2,305
+485
| +27% | +$95.5K | 0.05% | 197 |
|
|
2020
Q4 | $331K | Sell |
1,820
-382
| -17% | -$65K | 0.04% | 243 |
|
|
2020
Q3 | $368K | Sell |
2,202
-354
| -14% | -$59.6K | 0.05% | 184 |
|
|
2020
Q2 | $415K | Sell |
2,556
-87
| -3% | -$15.6K | 0.06% | 168 |
|
|
2020
Q1 | $457K | Buy |
2,643
+366
| +16% | +$72.8K | 0.09% | 118 |
|
|
2019
Q4 | $467K | Buy |
2,277
+81
| +4% | +$16.6K | 0.07% | 136 |
|
|
2019
Q3 | $464K | Buy |
2,196
+618
| +39% | +$129K | 0.09% | 127 |
|
|
2019
Q2 | $306K | Buy |
1,578
+332
| +27% | +$61.2K | 0.06% | 168 |
|
|
2019
Q1 | $205K | Buy |
+1,246
| New | +$220K | 0.05% | 205 |
|
|
2017
Q1 | – | Sell |
-10,026
| Closed | -$1.16M | – | 93 |
|
|
2016
Q4 | $1.16M | Buy |
10,026
+175
| +2% | +$19.5K | 0.49% | 33 |
|
|
2016
Q3 | $1.03M | Hold |
9,851
| – | – | 0.48% | 32 |
|
|
2016
Q2 | $959K | Buy |
+9,851
| New | +$931K | 0.51% | 29 |
|
Other funds holding CME
Clarius Group LLC's CME Position: Q4 2025 in Review
Clarius Group LLC increased its CME Group (CME) stake by 0.46% in Q4 2025, buying an estimated $2.45K and bringing the position to 1,983 shares worth $542K. The position accounts for 0.03% of the portfolio, ranked #193.
Clarius Group LLC first reported a position in CME in Q2 2016 and has held it in 31 quarters since. The position peaked at $1.63M in Q4 2022. 1,732 funds tracked by Wall St. Rank hold CME as of Q4 2025.
- Clarius Group LLC held 1,983 shares of CME Group worth $542K as of Q4 2025.
- Clarius Group LLC bought 9 CME Group shares in Q4 2025, an estimated $2.45K.
- CME Group made up 0.03% of Clarius Group LLC's portfolio in Q4 2025, its #193 holding.
- Clarius Group LLC first reported a position in CME Group in Q2 2016 and has held it in 31 quarters since.
- Clarius Group LLC's CME Group position peaked at $1.63M in Q4 2022.
- 1,732 funds tracked by Wall St. Rank held CME Group as of Q4 2025.
Based on Clarius Group LLC's 13F filing for Q4 2025, filed 14 Jan 2026.